Global Pharmaceutical Fine Chemicals Market Analysis & Trends - Industry Forecast to 2025

  • ID: 4039771
  • Report
  • Region: Global
  • 194 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott
  • Albemarle Corporation
  • BASF SE
  • Clariant AG
  • Evonik Industries
  • Lonza Group Ltd
  • MORE
The Global Pharmaceutical Fine Chemicals Market is poised to grow at a CAGR of around XX% over the next decade. Some of the prominent trends that the market is witnessing include companies producing fine chemicals are making efforts towards development of efficient products, technological advancements in production procedures, expansion in the pharmaceutical industry in emerging regions and growth opportunities/investment opportunities.

Based on Chemicals the market is categorized into big molecules and small molecules.

Based on Type of Drug the market is categorized into non proprietary drugs and poprietary drugs.

As per Therapeutic Use the market is segmented into respiratory gastrointestinal, mucoskeletal, diabetes, metabolic system, cardiovascular, infectious diseases, neurological, oncological and other therapeutic uses.

This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Albemarle Corporation
  • BASF SE
  • Clariant AG
  • Evonik Industries
  • Lonza Group Ltd
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Companies Producing Fine Chemicals are Making Efforts towards Development of Efficient Products
3.1.2 Technological Advancements In Production Procedures
3.1.3 Expansion in the Pharmaceutical Industry in Emerging Regions
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Pharmaceutical Fine Chemicals Market, By Chemical
4.1 Big Molecules
4.1.1 Big Molecules Market Forecast to 2025 (US$ MN)
4.2 Small Molecules
4.2.1 Small Molecules Market Forecast to 2025 (US$ MN)

5 Pharmaceutical Fine Chemicals Market, By Type of Drug
5.1 Non Proprietary Drugs
5.1.1 Non Proprietary Drugs Market Forecast to 2025 (US$ MN)
5.2 Poprietary Drugs
5.2.1 Poprietary Drugs Market Forecast to 2025 (US$ MN)

6 Pharmaceutical Fine Chemicals Market, By Therapeutic Use
6.1 Respiratory
6.1.1 Respiratory Market Forecast to 2025 (US$ MN)
6.2 Gastrointestinal
6.2.1 Gastrointestinal Market Forecast to 2025 (US$ MN)
6.3 Mucoskeletal
6.3.1 Mucoskeletal Market Forecast to 2025 (US$ MN)
6.4 Diabetes
6.4.1 Diabetes Market Forecast to 2025 (US$ MN)
6.5 Metabolic System
6.5.1 Metabolic System Market Forecast to 2025 (US$ MN)
6.6 Cardiovascular
6.6.1 Cardiovascular Market Forecast to 2025 (US$ MN)
6.7 Infectious Diseases
6.7.1 Infectious Diseases Market Forecast to 2025 (US$ MN)
6.8 Neurological
6.8.1 Neurological Market Forecast to 2025 (US$ MN)
6.9 Oncological
6.9.1 Oncological Market Forecast to 2025 (US$ MN)
6.10 Other Therapeutic Uses
6.10.1 Other Therapeutic Uses Market Forecast to 2025 (US$ MN)

7 Pharmaceutical Fine Chemicals Market, By Geography
7.1 North America
7.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
7.1.1.1 US
7.1.1.2 Canada
7.1.1.3 Mexico
7.2 Europe
7.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
7.2.1.1 France
7.2.1.2 Germany
7.2.1.3 Italy
7.2.1.4 Spain
7.2.1.5 UK
7.2.1.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
7.3.1.1 China
7.3.1.2 Japan
7.3.1.3 India
7.3.1.4 Australia
7.3.1.5 New Zealand
7.3.1.6 Rest of Asia Pacific
7.4 Middle East
7.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
7.4.1.1 Saudi Arabia
7.4.1.2 UAE
7.4.1.3 Rest of Middle East
7.5 Latin America
7.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
7.5.1.1 Argentina
7.5.1.2 Brazil
7.5.1.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
7.6.1.1 Africa
7.6.1.2 Caribbean

8 Key Player Activities
8.1 Mergers & Acquisitions
8.2 Partnerships, Joint Venture’s, Collaborations and Agreements
8.3 Product Launch & Expansions
8.4 Other Activities

9 Leading Companies
9.1 Abbott
9.2 Akzo Nobel N.V
9.3 Albemarle Corporation
9.4 AstraZeneca
9.5 BASF SE
9.6 Boehringer Ingelheim GmbH
9.7 Clariant AG
9.8 Eastman Chemical Company
9.9 Evonik Industries
9.10 GlaxoSmithKlein
9.11 Lonza Group Ltd
9.12 Merck and co.
9.13 Roche
9.14 Royal DSM N.V.
9.15 The Dow Chemical Company

List of Tables

Table 1 Global Pharmaceutical Fine Chemicals Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Pharmaceutical Fine Chemicals Market By Chemicals, Market Forecast (2013-2025) (US $MN)
Table 3 Global Pharmaceutical Fine Chemicals Market By Big Molecules, Market Forecast (2013-2025) (US $MN)
Table 4 Global Pharmaceutical Fine Chemicals Market By Small Molecules , Market Forecast (2013-2025) (US $MN)
Table 5 Global Pharmaceutical Fine Chemicals Market By Type of Drug, Market Forecast (2013-2025) (US $MN)
Table 6 Global Pharmaceutical Fine Chemicals Market By Non Proprietary Drugs, Market Forecast (2013-2025) (US $MN)
Table 7 Global Pharmaceutical Fine Chemicals Market By Poprietary, Market Forecast (2013-2025) (US $MN)
Table 8 Global Pharmaceutical Fine Chemicals Market By Therapeutic Use, Market Forecast (2013-2025) (US $MN)
Table 9 Global Pharmaceutical Fine Chemicals Market By Respiratory, Market Forecast (2013-2025) (US $MN)
Table 10 Global Pharmaceutical Fine Chemicals Market By Gastrointestinal, Market Forecast (2013-2025) (US $MN)
Table 11 Global Pharmaceutical Fine Chemicals Market By Mucoskeletal, Market Forecast (2013-2025) (US $MN)
Table 12 Global Pharmaceutical Fine Chemicals Market By Diabetes, Market Forecast (2013-2025) (US $MN)
Table 13 Global Pharmaceutical Fine Chemicals Market By Metabolic System, Market Forecast (2013-2025) (US $MN)
Table 14 Global Pharmaceutical Fine Chemicals Market By Cardiovascular, Market Forecast (2013-2025) (US $MN)
Table 15 Global Pharmaceutical Fine Chemicals Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 16 Global Pharmaceutical Fine Chemicals Market By Neurological, Market Forecast (2013-2025) (US $MN)
Table 17 Global Pharmaceutical Fine Chemicals Market By Oncological, Market Forecast (2013-2025) (US $MN)
Table 18 North America Pharmaceutical Fine Chemicals Market By Country, Market Forecast (2013-2025) (US $MN)
Table 19 North America Pharmaceutical Fine Chemicals Market By Chemicals, Market Forecast (2013-2025) (US $MN)
Table 20 North America Pharmaceutical Fine Chemicals Market By Big Molecules, Market Forecast (2013-2025) (US $MN)
Table 21 North America Pharmaceutical Fine Chemicals Market By Small Molecules , Market Forecast (2013-2025) (US $MN)
Table 22 North America Pharmaceutical Fine Chemicals Market By Type of Drug, Market Forecast (2013-2025) (US $MN)
Table 23 North America Pharmaceutical Fine Chemicals Market By Non Proprietary Drugs, Market Forecast (2013-2025) (US $MN)
Table 24 North America Pharmaceutical Fine Chemicals Market By Poprietary, Market Forecast (2013-2025) (US $MN)
Table 25 North America Pharmaceutical Fine Chemicals Market By Therapeutic Use, Market Forecast (2013-2025) (US $MN)
Table 26 North America Pharmaceutical Fine Chemicals Market By Respiratory, Market Forecast (2013-2025) (US $MN)
Table 27 North America Pharmaceutical Fine Chemicals Market By Gastrointestinal, Market Forecast (2013-2025) (US $MN)
Table 28 North America Pharmaceutical Fine Chemicals Market By Mucoskeletal, Market Forecast (2013-2025) (US $MN)
Table 29 North America Pharmaceutical Fine Chemicals Market By Diabetes, Market Forecast (2013-2025) (US $MN)
Table 30 North America Pharmaceutical Fine Chemicals Market By Metabolic System, Market Forecast (2013-2025) (US $MN)
Table 31 North America Pharmaceutical Fine Chemicals Market By Cardiovascular, Market Forecast (2013-2025) (US $MN)
Table 32 North America Pharmaceutical Fine Chemicals Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 33 North America Pharmaceutical Fine Chemicals Market By Neurological, Market Forecast (2013-2025) (US $MN)
Table 34 North America Pharmaceutical Fine Chemicals Market By Oncological, Market Forecast (2013-2025) (US $MN)
Table 35 Europe Pharmaceutical Fine Chemicals Market By Country, Market Forecast (2013-2025) (US $MN)
Table 36 Europe Pharmaceutical Fine Chemicals Market By Chemicals, Market Forecast (2013-2025) (US $MN)
Table 37 Europe Pharmaceutical Fine Chemicals Market By Big Molecules, Market Forecast (2013-2025) (US $MN)
Table 38 Europe Pharmaceutical Fine Chemicals Market By Small Molecules , Market Forecast (2013-2025) (US $MN)
Table 39 Europe Pharmaceutical Fine Chemicals Market By Type of Drug, Market Forecast (2013-2025) (US $MN)
Table 40 Europe Pharmaceutical Fine Chemicals Market By Non Proprietary Drugs, Market Forecast (2013-2025) (US $MN)
Table 41 Europe Pharmaceutical Fine Chemicals Market By Poprietary, Market Forecast (2013-2025) (US $MN)
Table 42 Europe Pharmaceutical Fine Chemicals Market By Therapeutic Use, Market Forecast (2013-2025) (US $MN)
Table 43 Europe Pharmaceutical Fine Chemicals Market By Respiratory, Market Forecast (2013-2025) (US $MN)
Table 44 Europe Pharmaceutical Fine Chemicals Market By Gastrointestinal, Market Forecast (2013-2025) (US $MN)
Table 45 Europe Pharmaceutical Fine Chemicals Market By Mucoskeletal, Market Forecast (2013-2025) (US $MN)
Table 46 Europe Pharmaceutical Fine Chemicals Market By Diabetes, Market Forecast (2013-2025) (US $MN)
Table 47 Europe Pharmaceutical Fine Chemicals Market By Metabolic System, Market Forecast (2013-2025) (US $MN)
Table 48 Europe Pharmaceutical Fine Chemicals Market By Cardiovascular, Market Forecast (2013-2025) (US $MN)
Table 49 Europe Pharmaceutical Fine Chemicals Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 50 Europe Pharmaceutical Fine Chemicals Market By Neurological, Market Forecast (2013-2025) (US $MN)
Table 51 Europe Pharmaceutical Fine Chemicals Market By Oncological, Market Forecast (2013-2025) (US $MN)
Table 52 Asia Pacific Pharmaceutical Fine Chemicals Market By Country, Market Forecast (2013-2025) (US $MN)
Table 53 Asia Pacific Pharmaceutical Fine Chemicals Market By Chemicals, Market Forecast (2013-2025) (US $MN)
Table 54 Asia Pacific Pharmaceutical Fine Chemicals Market By Big Molecules, Market Forecast (2013-2025) (US $MN)
Table 55 Asia Pacific Pharmaceutical Fine Chemicals Market By Small Molecules , Market Forecast (2013-2025) (US $MN)
Table 56 Asia Pacific Pharmaceutical Fine Chemicals Market By Type of Drug, Market Forecast (2013-2025) (US $MN)
Table 57 Asia Pacific Pharmaceutical Fine Chemicals Market By Non Proprietary Drugs, Market Forecast (2013-2025) (US $MN)
Table 58 Asia Pacific Pharmaceutical Fine Chemicals Market By Poprietary, Market Forecast (2013-2025) (US $MN)
Table 59 Asia Pacific Pharmaceutical Fine Chemicals Market By Therapeutic Use, Market Forecast (2013-2025) (US $MN)
Table 60 Asia Pacific Pharmaceutical Fine Chemicals Market By Respiratory, Market Forecast (2013-2025) (US $MN)
Table 61 Asia Pacific Pharmaceutical Fine Chemicals Market By Gastrointestinal, Market Forecast (2013-2025) (US $MN)
Table 62 Asia Pacific Pharmaceutical Fine Chemicals Market By Mucoskeletal, Market Forecast (2013-2025) (US $MN)
Table 63 Asia Pacific Pharmaceutical Fine Chemicals Market By Diabetes, Market Forecast (2013-2025) (US $MN)
Table 64 Asia Pacific Pharmaceutical Fine Chemicals Market By Metabolic System, Market Forecast (2013-2025) (US $MN)
Table 65 Asia Pacific Pharmaceutical Fine Chemicals Market By Cardiovascular, Market Forecast (2013-2025) (US $MN)
Table 66 Asia Pacific Pharmaceutical Fine Chemicals Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 67 Asia Pacific Pharmaceutical Fine Chemicals Market By Neurological, Market Forecast (2013-2025) (US $MN)
Table 68 Asia Pacific Pharmaceutical Fine Chemicals Market By Oncological, Market Forecast (2013-2025) (US $MN)
Table 69 RoW Pharmaceutical Fine Chemicals Market By Country, Market Forecast (2013-2025) (US $MN)
Table 70 RoW Pharmaceutical Fine Chemicals Market By Chemicals, Market Forecast (2013-2025) (US $MN)
Table 71 RoW Pharmaceutical Fine Chemicals Market By Big Molecules, Market Forecast (2013-2025) (US $MN)
Table 72 RoW Pharmaceutical Fine Chemicals Market By Small Molecules , Market Forecast (2013-2025) (US $MN)
Table 73 RoW Pharmaceutical Fine Chemicals Market By Type of Drug, Market Forecast (2013-2025) (US $MN)
Table 74 RoW Pharmaceutical Fine Chemicals Market By Non Proprietary Drugs, Market Forecast (2013-2025) (US $MN)
Table 75 RoW Pharmaceutical Fine Chemicals Market By Poprietary, Market Forecast (2013-2025) (US $MN)
Table 76 RoW Pharmaceutical Fine Chemicals Market By Therapeutic Use, Market Forecast (2013-2025) (US $MN)
Table 77 RoW Pharmaceutical Fine Chemicals Market By Respiratory, Market Forecast (2013-2025) (US $MN)
Table 78 RoW Pharmaceutical Fine Chemicals Market By Gastrointestinal, Market Forecast (2013-2025) (US $MN)
Table 79 RoW Pharmaceutical Fine Chemicals Market By Mucoskeletal, Market Forecast (2013-2025) (US $MN)
Table 80 RoW Pharmaceutical Fine Chemicals Market By Diabetes, Market Forecast (2013-2025) (US $MN)
Table 81 RoW Pharmaceutical Fine Chemicals Market By Metabolic System, Market Forecast (2013-2025) (US $MN)
Table 82 RoW Pharmaceutical Fine Chemicals Market By Cardiovascular, Market Forecast (2013-2025) (US $MN)
Table 83 RoW Pharmaceutical Fine Chemicals Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 84 RoW Pharmaceutical Fine Chemicals Market By Neurological, Market Forecast (2013-2025) (US $MN)
Table 85 RoW Pharmaceutical Fine Chemicals Market By Oncological, Market Forecast (2013-2025) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Akzo Nobel N.V
  • Albemarle Corporation
  • AstraZeneca
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Clariant AG
  • Eastman Chemical Company
  • Evonik Industries
  • GlaxoSmithKlein
  • Lonza Group Ltd
  • Merck and co.
  • Roche
  • Royal DSM N.V.
  • The Dow Chemical Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll